Raymond James Financial Services Advisors, Inc. Catalyst Biosciences, Inc. Transaction History

Raymond James Financial Services Advisors, Inc.

$73.5 Billion
Q3 2024

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 08, 2022	SELL	$0.91 - $4.16 $45,328 - $207,217	-49,812 Closed	0 $0
Q3 2021 Nov 02, 2021	SELL	$3.78 - $5.18 $850 - $1,165	-225 Reduced 0.45%	49,812 $205,000
Q2 2021 Aug 11, 2021	SELL	$4.1 - $5.33 $211,149 - $274,495	-51,500 Reduced 50.72%	50,037 $217,000
Q1 2021 May 14, 2021	BUY	$4.93 - $7.15 $107,449 - $155,834	21,795 Added 27.33%	101,537 $512,000
Q4 2020 Feb 12, 2021	BUY	$4.55 - $7.29 $181,062 - $290,098	39,794 Added 99.61%	79,742 $503,000
Q3 2020 Nov 04, 2020	SELL	$4.22 - $6.04 $7,363 - $10,539	-1,745 Reduced 4.19%	39,948 $172,000
Q2 2020 Jul 17, 2020	BUY	$3.76 - $8.01 $156,765 - $333,960	41,693 New	41,693 $245,000

Others Institutions Holding CBIO

# of Institutions

Shares Held

215

Call Options Held

Put Options Held

American Portfolios Advisors Holbrook, NY

215
Shares

$0
0.0% of portfolio

View Full List

About CATALYST BIOSCIENCES, INC.

Ticker CBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,477,100
Description
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...

More about CBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.

Account